Overview
Haruka Hiroki practices practicing medicine in Tokyo, Japan.
Her clinical expertise encompasses X-Linked Lymphoproliferative Disease, Primary Immunodeficiency (PID), Severe Combined Immunodeficiency (SCID), and Activated PI3K Delta Syndrome (APDS).
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haruka Hiroki
Is Haruka Hiroki a top-rated expert for X-Linked Lymphoproliferative Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Haruka Hiroki is classified as an Experienced expert for X-Linked Lymphoproliferative Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haruka Hiroki participate in research or clinical trials?
Yes. Haruka Hiroki has published 8 articles and abstracts on conditions like X-Linked Lymphoproliferative Disease. You can view a list of Haruka Hiroki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Activated PI3K Delta Syndrome (APDS)Ms. Hiroki isExperienced. Learn about Activated PI3K Delta Syndrome (APDS).
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelogenous Leukemia (CML)Ms. Hiroki isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Hiroki isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- LeukemiaMs. Hiroki isExperienced. Learn about Leukemia.
- Lymphoid HyperplasiaMs. Hiroki isExperienced. Learn about Lymphoid Hyperplasia.
- Primary Immunodeficiency (PID)Ms. Hiroki isExperienced. Learn about Primary Immunodeficiency (PID).
- Severe Combined Immunodeficiency (SCID)Ms. Hiroki isExperienced. Learn about Severe Combined Immunodeficiency (SCID).
- X-Linked Lymphoproliferative DiseaseMs. Hiroki isExperienced. Learn about X-Linked Lymphoproliferative Disease.